ArticleRSC medicinal chemistry2024

A new class of 7-deazaguanine agents targeting autoimmune diseases: dramatic reduction of synovial fibroblast IL-6 production from human rheumatoid arthritis patients and improved performance against murine experimental autoimmune encephalomyelitis.

Michelle Cotter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.